Zhuhai Encode Medical Engineering Co., Ltd approved public transfer on National Equities Exchange and Quotations by negotiating transfer.

Notice shows that Dongguan Securities is the host broker of Encode Medical, Ruihua Certifief Public Accountants responsible for financial audit, Guangdong Huaxinda Law Firm is the special legal adviser

Encode Medical was founded in May,2006, and finished the share reform in Jun, 2015. Main business including research, production and sales in-vitro diagnostic reagents, which area used for laboratory diagnosis of mycoplasma, chlamydia, pneumonia, pathogenic fungus, tuberculosis, bacterial vaginosis, neisseria gonorrhoeae, etc.